Anti-DR6 antibodies and methods of immune regulation

Antigen binding proteins that bind CCR2

Monovalent antigen binding constructs targeting EGFR and/or HER2 and uses thereof

Amino acid sequences that modulate the interaction between cells of the immune system

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Isolated DNA sequences encoding, and methods for making, antibody molecules having binding specificity for human IL-13

Human anti-IL-33 neutralizing monoclonal antibody

IL-17A binding agent and uses thereof

ANTI-CCL2 ANTIBODIES FOR TREATMENT OF SCLERODERMA

Compositions and methods for growth factor modulation

Antibodies that specifcally bind Sost and Wise peptides

Treatment of cancer using anti-TGF-BETA and PD-1 antibodies

HIV-1 broadly neutralizing antibodies

Hybrid influenza seed viruses, compositions thereof, and use thereof in the diagnosis or therapy of influenza

METHODS AND COMPOSITIONS FOR THE TREATMENT OF HCMV

Anti-WT1/HLA bi-specific antibody

Anti-LAMP1 antibodies and antibody drug conjugates, and uses thereof

Polynucleotide encoding antibody to human IL-3 receptor alpha chain

DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF

Amino acid sequences that modulate the interaction between cells of the immune system

Antibodies Directed to GPNMB and Uses Thereof

Compositions and methods for antibodies targeting Epo

HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)

Human antibody molecules for IL-13

Anti-ricin antibodies and uses thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Human cytomegalovirus neutralizing antibodies and use thereof

Hyper-glycosylated antibodies with selective Fc receptor binding

Human IgG1 derived antibody with pro-apoptotic activity

Engineered high-affinity human t cell receptors

Engineered high-affinity human T cell receptors

Internalizing ErbB2 Antibodies

EXTRACELLULAR TARGETED DRUG CONJUGATES

Compositions and methods for treating and preventing infections

Cancer markers and methods of use thereof

Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

PTK7 modulators and methods of use

Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity

Method for inhibiting the immune suppressive function of human T regulatory cells by administering an anti-GARP monoclonal antibody

Chemokine receptor binding polypeptides

Targeting tissue factor to activated platelets

VSTM5 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER, INFECTIOUS DISEASES AND IMMUNE RELATED DISEASES

IL-13 BINDING PROTEINS AND USES THEREOF

TNF-ALPHA BINDING PROTEINS

HUMANIZED ANTIBODY

PRE-HAPTOGLOBIN-2 MONOCLONAL ANTIBODIES AND USES THEREOF

Human neutralizing anti-kit antibodies and uses thereof

Anti-ErbB3 antibodies

Antibodies for treatment of cancer expressing claudin 6

Methods of treating aplastic anemia by administering anti-CD26 antibodies

Altered APRIL binding antibodies

Antibodies specific to FcRn

Method for generation of immunoglobulin sequences

ANTI-PODOCALYXIN ANTIBODIES AND METHODS OF USING THE SAME

TEM8 antibodies and their use in treatment and detection of tumors

IL-3 BLOCKADE IN SYSTEMIC LUPUS ERYTHEMATOSUS AND MULTIPLE SCLEROSIS

Anti-TNF antibodies, compositions, methods and uses

TSLP Binding Proteins

Anti-NGF antibodies and their use

Nucleic acids encodng anti-C5A antibodies

Modulators and methods of use

Glycans as functional cancer targets and antibodies thereto

ANTI-TENASCIN-C A2 ANTIBODIES AND METHODS OF USE

Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody

Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (MERS-CoV) and engineered bispecific fusions with inhibitory peptides

Antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Immunoconjugates

Coagulation Factor-Targeting to TLT-1 on Activated Platelets

Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

HER2/neu-Specific Antibodies and Methods of Using Same

Conjugated antibodies against LY75 for the treatment of cancer

Antibody therapeutics that bind JAG1

Antibody therapeutics that bind TIM3

Antibodies against CCR9 and methods of use thereof

Methods of treating cancers using PD-1 axis binding antagonists and taxanes

Antibody therapeutics that bind CD47

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

V-C-FC-V-C ANTIBODY

Antibodies specific for TROP-2 and their uses

Modulators and methods of use

Dual specific antibodies

Human antibodies against eotaxin and their use

Connective Tissue Growth Factor Antibodies

ANTI-VEGF ANTIBODIES

ANTI-TRANSTHYRETIN ANTIBODIES

ANTI-TRANSTHYRETIN ANTIBODIES

ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 161P2F10B PROTEINS

Antibody-SN-38 immunoconjugates with a CL2A linker

Nanoparticle complexes of albumin, paclitaxel, and anti-VEGF antibody for treatment of cancer

Aldolases, nucleic acids encoding them and methods for making and using them

Antibody specific to , therapeutic method and detection method using same

IL-17 receptor A antigen binding proteins

Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) antibodies

BISPECIFIC NANOBODIES

Anti-PD-1 antibodies

Anti-C5 antibodies having improved pharmacokinetics

Human PAC1 antibodies

Anti-DLL3 antibody drug conjugates

Anti-BAFF-anti-IL-17 bispecific antibodies

NEUTRALISING ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN IL-17

Stable and soluble antibodies inhibiting TNF alpha

Uses and Compositions for Treatment of Ankylosing Spondylitis

Antibodies to tau and uses thereof

ANTIBODIES RECOGNIZING MEDIN

Humanized antibodies that recognize alpha-synuclein

Antibody molecules to dengue virus and uses thereof

RSV-specific binding molecule

Animal models and therapeutic molecules

AH-7921 Detection

ANTI-TRKA ANTIBODIES, DERIVATIVES AND USES THEREOF

Antibody therapeutics that bind CD137

ANTIBODIES

ANTIBODIES WITH MODIFIED AFFINITY TO FCRN THAT PROMOTE ANTIGEN CLEARANCE

Anti-PVRIG antibodies and methods of use

Antibodies to M-CSF

Human anti-alpha-synuclein antibodies

Anti-EPCAM antibodies and methods of use

Binding molecules specific for HER3 and uses thereof

Antibody therapeutics that bind CTLA4

Na1.7 antibodies and methods of using the same

Human anti-IL-23 antibodies, compositions, methods and uses

Manufacturing methods to control C-terminal lysine, galactose and sialic acid content in recombinant proteins

Human Anti-NGF Neutralizing Antibodies As Selective NGF Pathway Inhibitors

Binding moieties for biofilm remediation

SlyD FKBP domain specific antibodies

Synthetic single domain antibody

Nanoparticle complexes of paclitaxel, trastuzumab, and albumin

Heterodimeric antibodies that bind CD3 and tumor antigens

ANTI-CEA ANTIBODIES

Antibodies for botulinum neurotoxins

Mesothelin domain-specific monoclonal antibodies and use thereof

TUMOR SELECTIVE ANTIBODIES SPECIFIC TO ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR PROTEIN

Antagonist anti-IL-7 receptor antibodies and methods

High affinity antibodies to human IL-6 receptor

Antibody specific for CD22 and methods of use thereof

TM4SF1 binding proteins and methods of using same

Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

IL-8 antibodies

Anti-DLL3 antibody drug conjugates

Anti-EGFR activatable antibodies

Anti-human tie-2 antibody

Material and methods for treating or preventing HER-3 associated diseases

NUCLEIC ACID ENCODING ANTI-PD-L1 ANTIBODIES

Fully human antibodies to BTLA

Antibodies against PD-1 and uses thereof

FC RECEPTOR BINDING PROTEINS

Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof

Pen-injector device containing anti-IL-6 antibodies

Non-human mammals for the production of chimeric antibodies

Non-human mammals for the production of chimeric antibodies

Compositions and methods for treatment of diabetic retinopathy

COMBINATION THERAPY OF ANTIBODIES AGAINST HUMAN CSF-1R AND TLR9 AGONIST

Non-human mammals for the production of chimeric antibodies

Non-human mammals for the production of chimeric antibodies

Non-human mammals for the production of chimeric antibodies

Animal models and therapeutic molecules

Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer

Anti-CEP antibody or fragment thereof

NSP4 inhibitors and methods of use

Antibodies specific for urokinase-type plasminogen activator and methods of use thereof

Heterodimeric antibodies that bind CD3 and CD38

Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO FcGammaRIIB

ICOS binding proteins

Humanized anti-ACTH antibodies and use thereof

IL-18 binding protein (IL-18BP) in inflammatory diseases

VEGFA/Ang2 Compounds

Product and method for treating sarcopenia

Human antibodies to ebola virus glycoprotein

Novel Delivery Compositions and Methods of Using Same

T CELL ACTIVATING BISPECIFIC ANTIGEN BINDING MOLECULES

ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR ROR1

Human monoclonal antibodies specific for glypican-3 and use thereof

Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU

Anti-human TSLP receptor antibody

Antibodies

Anti-human folate receptor beta antibodies and methods of use

Anti-ricin antibodies and uses thereof

Methods of treating complement-associated disorders with anti-C5a antibodies

ANTIBODIES TO COMPLEX TARGETS

ANTI-IL-4 ANTIBODIES AND BISPECIFIC ANTIBODIES AND USES THEREOF

MODULATORS OF IL-12 AND/OR IL-23 FOR THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE

ANTIGEN-BINDING CONSTRUCTS

Therapeutic Antibody

Monoclonal antibody and derivatives

Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methods

Antibody and recombinant derivative for the detection of trinitrotoluene

Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules

Antibodies to plasminogen activator inhibitor-1 (PAI-1) and uses thereof

Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

Antibodies

METHOD FOR THE TREATMENT OF FIBROTIC DISEASE

ANTIBODIES THAT INHIBIT TIM-3:LILRB2 INTERACTIONS AND USES THEREOF

LRP-8 binding dual variable domain immunoglobulin proteins

Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use

Complement Pathway Inhibitors Binding To C5 And C5a Without Preventing The Formation Of C5b

Monoclonal antibodies that neutralize anthrax toxins

Anti-Ly6E antibodies and immunoconjugates and methods of use

Methods for treating cancer using an immunotoxin

Disease characterization from fused pathology and radiology data

Combinatorial antibody libraries and uses thereof

Binding agent

Bispecific CD33 and CD3 binding proteins

Anti-PCSK9 antibodies and use thereof

Binding molecules specific for CD73 and uses thereof

ANTI-TISSUE FACTOR ANTIBODIES AND COMPOSITIONS

CD70-BINDING PEPTIDES AND METHOD, PROCESS AND USE RELATING THERETO

Antibody which specifically reacts with human integrin A6B4

Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same

Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

Fusion proteins and their related methods

Antibodies against frizzled receptor

Antibody derivatives

FC-RECEPTOR BINDING MODIFIED ASYMMETRIC ANTIBODIES AND METHODS OF USE

COMPOSITIONS AND METHODS FOR THE REMOVAL OF BIOFILMS

Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use

Means and methods for producing high affinity antibodies

ANTIGEN BINDING PROTEINS

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Methods of treating generalized pustular psoriasis (GPP) using IL-17 antagonists

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

LOX AND LOXL2 INHIBITORS AND USES THEREOF

Humanized alpha-enolase specific antibodies and methods of uses in cancer therapy

SERUM ALBUMIN BINDING PEPTIDES FOR TUMOR TARGETING

Anti-CSF1R antibodies for treating PVNS

Affinity matured anti-CCR4 humanized monoclonal antibodies and methods of use

Anti-5T4 antibodies and uses thereof

Humanized antibodies to LIV-1 and use of same to treat cancer

Anti-Fc-gamma receptor IIB antibodies and uses thereof

Anti-LRP5 antibodies and methods of use

CANCER TREATMENT USING ANTIBODIES THAT BIND CELL SURFACE GRP78

Anti-Notch3 antibodies

Uses of antibodies to interleukin-6 in cancer treatment

Stable and soluble antibodies inhibiting TNFα

USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF INFLAMMATION AND BACTERIAL INFECTIONS

ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS

Human antibodies and uses therefor

CELL-TARGETED MOLECULES COMPRISING AMINO-TERMINUS PROXIMAL OR AMINO-TERMINAL SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS

Humanized monoclonal antibodies and methods of use

Cytotoxic immunoglobulin

Fc variants with altered binding to FcRn

Anti-GD2 antibodies

T-cell redirecting bispecific antibodies for treatment of disease

Methods and compositions related to single chain antibody fragments that bind to tumor-associated glycoprotein 72 (TAG-72)

Methods and compositions relating to anti-IL-21 receptor antibodies

PEPTIDE OR PEPTIDE COMPLEX BINDING TO ALPHA2 INTEGRIN AND METHODS AND USES INVOLVING THE SAME

CYTOTOXIC ANTI-LAG-3 MONOCLONAL ANTIBODY AND ITS USE IN THE TREATMENT OR PREVENTION OF ORGAN TRANSPLANT REJECTION AND AUTOIMMUNE DISEASE

Antibodies to TIGIT

Method of modulating the activity of adrenomedullin in a subject in need of therapeutic intervention for organ dysfunction or organ failure associated with adranomedullin (ADM) activity by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment to the subject

Compositions and methods for antibodies targeting BMP6

Anti-C5 antibodies

Human antibodies to influenza hemagglutinin

Synthetic library of specific binding molecules

Anti-immunoglobulin E antibodies and methods of using thereof

Human anti-SOD1 antibodies

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

Antibodies directed to HER-3 and uses thereof

Antibodies to MUC16 and methods of use thereof

ANTIBODIES FOR GUANYLYL CYCLASE RECEPTORS

Anti-FGFR3 antibodies and methods using same

Human monoclonal antibodies to O8E

Humanized or chimeric CD3 antibodies

Methods of using anti-CGRP antagonist antibodies

Antagonists to IL-6 to raise albumin and/or lower CRP

Anti-interleukin-33 antibodies and uses thereof

Methods for isolating antibodies that bind sclerostin

HUMANIZED, ANTI-N2 ANTIBODIES AND METHODS OF TREATING ISCHEMIA-REPERFUSION INJURY

Anti-galectin-1 monoclonal antibodies and fragments thereof

HUMANIZED ANTIBODY IGG1

Antibody multimerization technologies

Protein ligand for affinity isolation matrix

Animal models and therapeutic molecules

Dual-targeting protein binding specifically to DLL4 and VEGF and use thereof

Humanized antibodies with ultralong complementary determining regions

Antibodies that bind urokinase plasminogen activator

ANTIBODIES TO MATRIX METALLOPROTEINASE 9

Coiled coil immunoglobulin fusion proteins and compositions thereof

Therapeutic Agent Comprising Humanized Anti-Epiregulin Antibody as Active Ingredient for Non-Small-Cell Lung Carcinoma Excluding Adenocarcinoma

Trimeric antigen binding molecules

Antibody constant region variant

Binding molecules specific for HER3 and uses thereof

COMBINATION THERAPY OF ANTI-HER3 ANTIBODIES

Anti-B7-H4 antibodies and immunoconjugates

Anti-CD79b antibodies and methods of use

Anti-PD-1 antibodies and methods of use thereof

Methods of inhibiting growth of a colon cancer tumor in a subject by administering monoclonal antibodies to G protein-coupled receptor 49 (GPR49)

Methods of modulating the activity of adrenomedullin in a subject in need of regulation of fluid balance by administering an anti-adrenomedullin (ADM) antibody or an anti-ADM antibody fragment

Human FcRn-binding modified antibodies and methods of use

Anti-C5a antibodies

METHODS OF TREATMENT FOR ALZHEIMER'S DISEASE AND HUNTINGTON'S DISEASE

Anti-S100A4 antibody molecules and their uses

Insertable variable fragments of antibodies and modified A1-A2 domains of NKG2D ligands

Antibodies for epidermal growth factor receptor 3 (HER3)

Monoclonal antibody recognizing human papillomavirus (HPV) L2 protein and method for measuring HPV-neutralizing antibody titer using the same

Humanized antibody or fragment thereof specific for CD45R0

ANTIBODIES THAT BIND NOTUM PECTINACETYLESTERASE

Antibodies recognizing the N-terminal part of tissue factor pathway inhibitor capable of eliciting pro-coagulant activity

Antibody binding sites specific for EGFRvIII

ANTIGEN-BINDING PROTEINS SPECIFIC FOR HLA-A2-RESTRICTED WILMS TUMOR 1 PEPTIDE